Back

Abbott Laboratories (ABT)
Health CareABT · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$93.93
−0.43%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$3.73
ROE
12.3%
Gross margin
56.5%
Debt/Equity
0.65x
Revenue growth
7.8%
Abbott Laboratories — company intelligence
Earnings surprises
Q1 2026$1.15 vs $1.16 est-0.5%
Q4 2025$1.50 vs $1.51 est-0.7%
Q3 2025$1.30 vs $1.31 est-1.1%
Q2 2025$1.26 vs $1.27 est-0.6%
Analyst consensus · 34 analysts
24 Buy10 Hold0 Sell
Updated Jul 4, 2026
Insider activity · 90 days
20 buys0 sellsnet +71,194 shares
Stratton John GBuy 2,000 · May 7, 2026
Moreland Mary KBuy 5,314 · Apr 28, 2026
STARKS DANIEL JBuy 10,000 · Apr 27, 2026
Recent SEC filings
4 — Insider transaction reportJul 1, 2026
4 — Insider transaction reportJul 1, 2026
4 — Insider transaction reportJul 1, 2026
Latest news
DXCM Grew. The Stock Did Not. Someone Is Wrong — Yahoo · 22h ago
Dividend Powerhouse: Abbott Laboratories (NYSE:ABT) Passes the Test for Sustainable Income — ChartMill · 1d ago
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM — Yahoo · 2d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Abbott Laboratories
Weekly undervalued picks (like ABT)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.